✦ LIBER ✦

Multiple myeloma presenting as intractable gastric retention in a patient with a previous gastroenterostomy

✍ Scribed by Mr C. R. Chapple; I. M. Chesner; J. Newman

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 160 KB
Volume: 73
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800731132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

130. PRAME gene as a marker of MRD in pa

130. PRAME gene as a marker of MRD in patients with multiple myeloma

✍ N.I. Bilous; A.V. Misiurin; I.V. Abramenko; I.A. Kryachok 📂 Article 📅 2003 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 106 KB

a dla erbB-2 1,34 (zakres od 0,11 do 9,9). Stwierdzono znamiennq zaleznosc po-mi~dzy AGCN dla obu gen6w. Nie stwierdzono znamiennego zwiqzku z jakimkolwiek gt6wnym parametrem klinicznym. Do czasu przeprowadzenia analizy zmarto 73 chorych (65%). Po czasie obserwacji o medianie 5,1 roku nie stwierdzon

Subcutaneous plasmacytomas with tropism

Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant

✍ Michael D. Rosenblum; Christopher N. Bredeson; Chung-Che Chang; J. Douglas Rizzo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Pulmonary veno-occlusive disease as a ca

Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation

✍ Pankaj Malhotra; Subhash Varma; Neelam Varma; Rati Ram Sharma; Sanjay Jain; Savi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views